VIA
STJ

Virtus Investment Advisers’s St Jude Medical STJ Stock Holding History

Virtus Investment Advisers’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,060
Closed -$646K – 523
2016
Q4 		$646K Sell
8,060
-8,323
-51% -$661K 0.05% 334
2016
Q3 		$1.31M Buy
+16,383
New +$1.32M 0.08% 268

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Virtus Investment Advisers's STJ Position: Q1 2017 in Review

Virtus Investment Advisers sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 8,060 shares — an estimated $646K sold.

Virtus Investment Advisers first reported a position in STJ in Q3 2016 and held it in 2 quarters. The position peaked at $1.31M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Virtus Investment Advisers reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Virtus Investment Advisers sold 8,060 St Jude Medical shares in Q1 2017, an estimated $646K.
  • Virtus Investment Advisers first reported a position in St Jude Medical in Q3 2016 and held it in 2 quarters.
  • Virtus Investment Advisers's St Jude Medical position peaked at $1.31M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Virtus Investment Advisers's 13F filing for Q1 2017, filed 15 May 2017.